Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livermore

Showing results (621-630 of 807) with videos related to

Pageof 81
Sort By:
Antimicrobial Agents and Chemotherapy|February 5, 2025
Guidelines vs mindlines: a qualitative investigation of how clinicians' beliefs influence the application of rapid molecular diagnostics in intensive careSarah-Jane F Stewart, Alyssa M Pandolfo, Yogini Jani, et al.
Haematologica|December 11, 2013
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in LeukemiaDiana Averbuch, Christina Orasch, Catherine Cordonnier, et al.
Mbio|August 24, 2017
Pharmacodynamics of the Orotomides against <i>Aspergillus fumigatus</i>: New Opportunities for Treatment of Multidrug-Resistant Fungal DiseaseWilliam W Hope, Laura McEntee, Joanne Livermore, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 15, 2010
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national expertsH Grundmann, D M Livermore, C G Giske, et al.
Antibiotics (Basel, Switzerland)|March 9, 2017
A Risk Assessment of Antibiotic Pan-Drug-Resistance in the UK: Bayesian Analysis of an Expert Elicitation StudyDaniel Carter, André Charlett, Stefano Conti, et al.
Haematologica|December 11, 2013
Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)Diana Averbuch, Catherine Cordonnier, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|July 12, 2011
False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porinsAlejandro Beceiro, Sunil Maharjan, Tom Gaulton, et al.
Clinical Pharmacokinetics|January 11, 2021
Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal ClearanceFekade Bruck Sime, Jason A Roberts, Rosalind L Jeffree, et al.
The Journal of Antimicrobial Chemotherapy|September 27, 2016
Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencingK Schmidt, S Mwaigwisya, L C Crossman, et al.
The Journal of Infectious Diseases|October 3, 2017
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavusClara E Negri, Adam Johnson, Laura McEntee, et al.
Pageof 81

Showing results (621-630 of 807) with videos related to

Sort By:
Pageof 81
Antimicrobial Agents and Chemotherapy|February 5, 2025
Guidelines vs mindlines: a qualitative investigation of how clinicians' beliefs influence the application of rapid molecular diagnostics in intensive careSarah-Jane F Stewart, Alyssa M Pandolfo, Yogini Jani, et al.
Haematologica|December 11, 2013
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in LeukemiaDiana Averbuch, Christina Orasch, Catherine Cordonnier, et al.
Mbio|August 24, 2017
Pharmacodynamics of the Orotomides against <i>Aspergillus fumigatus</i>: New Opportunities for Treatment of Multidrug-Resistant Fungal DiseaseWilliam W Hope, Laura McEntee, Joanne Livermore, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 15, 2010
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national expertsH Grundmann, D M Livermore, C G Giske, et al.
Antibiotics (Basel, Switzerland)|March 9, 2017
A Risk Assessment of Antibiotic Pan-Drug-Resistance in the UK: Bayesian Analysis of an Expert Elicitation StudyDaniel Carter, André Charlett, Stefano Conti, et al.
Haematologica|December 11, 2013
Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)Diana Averbuch, Catherine Cordonnier, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|July 12, 2011
False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porinsAlejandro Beceiro, Sunil Maharjan, Tom Gaulton, et al.
Clinical Pharmacokinetics|January 11, 2021
Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal ClearanceFekade Bruck Sime, Jason A Roberts, Rosalind L Jeffree, et al.
The Journal of Antimicrobial Chemotherapy|September 27, 2016
Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencingK Schmidt, S Mwaigwisya, L C Crossman, et al.
The Journal of Infectious Diseases|October 3, 2017
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavusClara E Negri, Adam Johnson, Laura McEntee, et al.
Pageof 81